Financials
- Market Capitalization 1.78 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-63.19
주가매출액비율
15.2
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 2070 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.56 USD | -3.64% | -7.33% | -5.60% | +91.72% | 1.81 B USD | ||
| 2079 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.35 USD | +0.30% | +2.45% | +10.56% | -27.02% | 1.79 B USD | ||
| 2094 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.54 USD | -2.56% | +0.64% | +18.41% | -8.60% | 1.76 B USD | ||
| 2104 | GHRS GH Research PLC - Ordinary Shares | 27.94 USD | -2.48% | -0.92% | -0.82% | +97.32% | 1.73 B USD |